Point72 Asset Management’s Castle Biosciences CSTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-236,218
| Closed | -$4.73M | – | 1414 |
|
|
2025
Q1 | $4.73M | Sell |
236,218
-310,886
| -57% | -$6.22M | 0.01% | 665 |
|
|
2024
Q4 | $14.6M | Buy |
547,104
+47,912
| +10% | +$1.28M | 0.03% | 463 |
|
|
2024
Q3 | $14.2M | Buy |
499,192
+445,415
| +828% | +$12.7M | 0.04% | 428 |
|
|
2024
Q2 | $1.17M | Buy |
+53,777
| New | +$1.17M | ﹤0.01% | 793 |
|
|
2023
Q4 | – | Sell |
-44,200
| Closed | -$747K | – | 1514 |
|
|
2023
Q3 | $747K | Buy |
+44,200
| New | +$747K | ﹤0.01% | 951 |
|
|
2023
Q2 | – | Sell |
-284,847
| Closed | -$6.47M | – | 1711 |
|
|
2023
Q1 | $6.47M | Buy |
284,847
+83,466
| +41% | +$1.9M | 0.02% | 602 |
|
|
2022
Q4 | $4.74M | Buy |
+201,381
| New | +$4.74M | 0.02% | 648 |
|
|
2022
Q2 | – | Sell |
-623,291
| Closed | -$28M | – | 1091 |
|
|
2022
Q1 | $28M | Buy |
623,291
+140,439
| +29% | +$6.3M | 0.11% | 222 |
|
|
2021
Q4 | $20.7M | Buy |
482,852
+379,673
| +368% | +$16.3M | 0.08% | 317 |
|
|
2021
Q3 | $6.86M | Buy |
+103,179
| New | +$6.86M | 0.03% | 552 |
|
|
2021
Q1 | – | Sell |
-81,145
| Closed | -$5.45M | – | 939 |
|
|
2020
Q4 | $5.45M | Buy |
+81,145
| New | +$5.45M | 0.03% | 540 |
|
|
2020
Q3 | – | Sell |
-44,022
| Closed | -$1.66M | – | 893 |
|
|
2020
Q2 | $1.66M | Buy |
44,022
+16,462
| +60% | +$620K | 0.01% | 583 |
|
|
2020
Q1 | $822K | Buy |
+27,560
| New | +$822K | 0.01% | 588 |
|